Searching journal content for treatment response (as phrase) in full text.

Displaying results 1-10 of 79

For checked items

view abstracts
download to citation manager

Select this article
Research:
- Zhu Wang,
- Dinglan Wu,
- Chi-Fai Ng,
- Jeremy Yuen-Chun Teoh,
- Shan Yu,
- Yuliang Wang,
- and Franky Leung Chan
Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer Endocr Relat Cancer ERC-17-0280, doi:10.1530/ERC-17-0280 first published on 17 October 2017
...treatment response or prognosis of CRPC patients 70 (Lallous, et al. 2016; Steinestel, et al. 2015). In some CRPC patients, the disease will evolve 71 Page 3 of 38 to a highly aggressive and treatment-resistant CRPC, characterized by acquired 72 neuroendocrine cell-specific phenotype and loss of AR, ~~~
Select this article
Review:
- Jolanta Krajewska,
- Ewa Chmielik,
- and Barbara Jarząb
Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017? Endocr Relat Cancer 24 (11) R387-R402, doi:10.1530/ERC-17-0270 first published on 18 August 2017
...treatment response (DRS low risk), whereas remaining 20.2% of patients were restratified at as DRS high-risk (among them 3.3% with biochemical incomplete response, 6.4% with incomplete structural response and 10.5% with indeterminate response). At the final follow-up, 83.6% of patients were free of ~~~
Select this article
Review:
- Takuma Uo,
- Stephen R Plymate,
- and Cynthia C Sprenger
Allosteric alterations in the androgen receptor and activity in prostate cancer Endocr Relat Cancer 24 (9) R335-R348, doi:10.1530/ERC-17-0108
...treatment response in prostate cancer. Nature Reviews Clinical Oncology 11 401–412. (doi:10.1038/nrclinonc.2014.82) Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J, et al. 2015 RNA-Seq of single prostate CTCs implicates noncanonical Wnt signa ~~~
Select this article
Research Letter:
- L Fishbein,
- S Ben-Maimon,
- S Keefe,
- K Cengel,
- D A Pryma,
- A Loaiza-Bonilla,
- D L Fraker,
- K L Nathanson,
- and D L Cohen
SDHB mutation carriers with malignant pheochromocytoma respond better to CVD Endocr Relat Cancer 24 (8) L51-L55, doi:10.1530/ERC-17-0086 first published on 31 May 2017
...treatment response ~~~
Select this article
Research:
- Theo S Plantinga,
- Mirela S Petrulea,
- Marije Oosting,
- Leo A B Joosten,
- Doina Piciu,
- Johannes W Smit,
- Romana T Netea-Maier,
- and Carmen E Georgescu
Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma Endocr Relat Cancer 24 (7) 307-318, doi:10.1530/ERC-17-0033 first published on 20 April 2017
...treatment response and outcome of NMTC patients was investigated. With regard to the NFKB1 rs4648068 SNP, no statistically significant differences were found in any of the patient cohorts for any of the selected clinical parameters. Interestingly, however, the NFKBIA rs2233406 SNP was significantly ~~~
Select this article
Research:
- Tessa Brabander,
- Wouter A van der Zwan,
- Jaap J M Teunissen,
- Boen L R Kam,
- Wouter W de Herder,
- Richard A Feelders,
- Eric P Krenning,
- and Dik J Kwekkeboom
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate Endocr Relat Cancer 24 (5) 243-251, doi:10.1530/ERC-16-0524 first published on 20 March 2017
...treatment response after PRRT. 354 Dutch patients with GEPNETs who were treated with 177Lu-DOTATATE between March 2000 and December 2011 were retrospectively selected. Liver function parameters and chromogranin A were measured before each therapy and in follow-up. Anatomical imaging was performed be ~~~
Select this article
Review:
- Bethany Smith,
- Priyanka Agarwal,
- and Neil A Bhowmick
MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine Endocr Relat Cancer 24 (5) R157-R172, doi:10.1530/ERC-16-0525 first published on 13 March 2017
...treatment response NCT02391051 Interventional University of Erlangen-Nürnberg Medical School Focal brachytherapy in patients with selected ‘low-risk’ prostate cancer – a phase-II-trial R165Review B Smith et al. MicroRNA toward cancer patient care DOI: 10.1530/ERC-16-0525 http://.endocrinology-journa ~~~
OPEN ACCESS ARTICLE
Select this article
Research:
- Misu Lee,
- Ninelia Minaskan,
- Tobias Wiedemann,
- Martin Irmler,
- Johannes Beckers,
- Behrooz H Yousefi,
- Georgios Kaissis,
- Rickmer Braren,
- Iina Laitinen,
- and Natalia S Pellegata
Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo Endocr Relat Cancer 24 (1) 1-15, doi:10.1530/ERC-16-0324 first published on 3 November 2016
...treatment response with diffusion-weighted MRI. Journal of Magnetic Resonance Imaging 32 2–16. (doi:10.1002/jmri.22167) Wiedemann T, Peitzsch M, Qin N, Neff F, Ehrhart-Bornstein M, Eisenhofer G & Pellegata NS 2016 Morphology, biochemistry and pathophysiology of MENX-related pheochromocytoma recapitu ~~~
Select this article
Editorial:
- Wayne D Tilley
Novel twists in hormone-mediated carcinogenesis Endocr Relat Cancer 23 (12) E9-E12, doi:10.1530/ERC-16-0466
...treatment response ~~~
Select this article
Thematic Review:
- John W Cassidy,
- Ankita S Batra,
- Wendy Greenwood,
- and Alejandra Bruna
Patient-derived tumour xenografts for breast cancer drug discovery Endocr Relat Cancer 23 (12) T259-T270, doi:10.1530/ERC-16-0251 first published on 4 October 2016
...treatment response and explore at which points PDTX models may be introduced into the drug discovery process. Tumour heterogeneity Complex patterns of inter- and intra-tumour heterogeneity are a defining feature of human malignancy. Although the past few years have seen an unprecedented increase in ~~~
OPEN ACCESS ARTICLE

For checked items

view abstracts
download to citation manager

Endocrine-Related Cancer

Searching journal content for treatment response (as phrase) in full text.

Search Results

Modify Results

This search

New Articles: issue in progress

Most

Viewed

Cited

Citation format:
Results / page:
Results order: